Teva-Kowa To Commence Marketing Generics In Japan In January

TOKYO - Teva-Kowa Pharma, a ¥360 million 50-50 joint venture of Teva - the world's largest generics manufacturer - and Japan's diversified manufacturer group Kowa, Dec. 16 said it would commence marketing generic drugs in Japan beginning in January, a few months ahead of schedule